EQ · NASDAQ
Equillium (EQ) Stock Price & Fundamentals
Equillium (EQ) closed at $469.04 on Oct 9, 2026, up 1.63% from the previous close of $461.53.
Share price, past year
1Y +42.66%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $469.04 |
| Sep 30, 2026 | $464.74 |
| Aug 31, 2026 | $477.03 |
| Jul 31, 2026 | $454.70 |
| Jun 30, 2026 | $439.07 |
| May 29, 2026 | $426.12 |
| Apr 30, 2026 | $417.23 |
| Mar 31, 2026 | $415.01 |
| Feb 27, 2026 | $380.71 |
| Jan 30, 2026 | $370.82 |
| Dec 31, 2025 | $347.07 |
| Nov 28, 2025 | $338.18 |
| Oct 31, 2025 | $343.40 |
Key statistics
- Market cap
- $29.74B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.09
- Revenue (TTM)
- —
- Net income (TTM)
- −$18.01M
- Shares outstanding
- 63.4M
- Dividend yield
- —
- 52-week range
- $320.29 – $486.95
Equillium's market cap is $29.74B, based on a share price of $469.04 and 63.4M shares outstanding as of Jun 30, 2026.
Financials
Equillium reported revenue of $41.10M for fiscal 2024, up 13.89% from fiscal 2023.
Equillium reported a net loss of $22.40M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $41.10M | +13.9% | −$8.07M | −19.6% | −$0.23 | −$19.11M |
| FY2023ended Dec 31, 2023 | $36.08M | +129.0% | −$13.34M | −37.0% | −$0.38 | −$21.83M |
| FY2022ended Dec 31, 2022 | $15.76M | — | −$62.43M | −396.1% | −$1.85 | −$9.01M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q4 FY2024ended Dec 31, 2024 | $4.39M | −$5.79M | −$0.16 |
| Q3 FY2024ended Sep 30, 2024 | $12.16M | −$7.00K | $0.00 |
| Q2 FY2024ended Jun 30, 2024 | $13.85M | — | — |
| Q1 FY2024ended Mar 31, 2024 | $10.69M | — | — |
| Q4 FY2023ended Dec 31, 2023 | $9.21M | — | — |
| Q3 FY2023ended Sep 30, 2023 | $8.87M | — | — |
| Q2 FY2023ended Jun 30, 2023 | $9.12M | — | — |
| Q1 FY2023ended Mar 31, 2023 | $8.88M | — | — |
Company profile
- Name
- Equillium, Inc.
- Ticker
- EQ
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 2223 Avenida De La Playa, Suite 105, La Jolla, CA 92037
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001746466
Recent SEC filings
- Oct 5, 2026
- Aug 13, 2026
- Aug 13, 2026
- May 29, 2026
- May 13, 2026
- May 13, 2026
- Mar 25, 2026
- Mar 25, 2026
Frequently asked questions
What is Equillium's stock price?
Equillium (EQ) closed at $469.04 on Oct 9, 2026, up 1.63% from the previous close of $461.53.
What is Equillium's market cap?
Equillium's market cap is $29.74B, based on a share price of $469.04 and 63.4M shares outstanding as of Jun 30, 2026.
How much revenue does Equillium make?
Equillium reported revenue of $41.10M for fiscal 2024, up 13.89% from fiscal 2023.
Does Equillium pay a dividend?
Equillium's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Equillium, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures